future earnings now take over mcap

Hi everyone,

With the latest news that GSK has already booked orders for 128 Million doses we are close to pass the Mcap of this company.

Hi guys,

I have to say looking at the fundamentals $1.60 must be a steal to buy more BTA.

Just have a quick look

BTA has 175 million shares on issue
BTA has about at $1.60 a Mcap of $280 Million
BTA has around $100 Million cash afer this week

GSK has already booked orders for 128 million doses

Royalty is 7%

1 packet Relenza sells for US$20

128 Million gives Biota around A$128 Million

Just remember we have around $100 Million in the bank
after this week

So the future earnings we KNOW off and the cash in the bank are now around $228 Million

Mcap at $1.60 = $280 Million

You get my thouhgts this company is just CHEAP AS CHIPS and has to at least double from here.

I think that BTA should put out an ASX announcement on this latest news from GSK and forward Relenza sales.

If this is not market sensitive Information , then I do not know what is.

Please do your own research as I own shares in this company and have a biast opinion.

Good luck to all

jojo